- Home
- Publications
- Publication Search
- Publication Details
Title
Androgen receptor signaling in prostate cancer
Authors
Keywords
Androgen receptor, miRNA, Migration, Mutation, Coactivator, Truncated receptor
Journal
CANCER AND METASTASIS REVIEWS
Volume 33, Issue 2-3, Pages 413-427
Publisher
Springer Nature
Online
2014-01-02
DOI
10.1007/s10555-013-9474-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100)
- (2013) Y. Loriot et al. ANNALS OF ONCOLOGY
- The Steroid Receptor Coactivator-3 Is Required for the Development of Castration-Resistant Prostate Cancer
- (2013) Jean C-Y. Tien et al. CANCER RESEARCH
- Hsp27 Regulates Epithelial Mesenchymal Transition, Metastasis, and Circulating Tumor Cells in Prostate Cancer
- (2013) M. Shiota et al. CANCER RESEARCH
- PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer
- (2013) Giovanni Luca Gravina et al. ENDOCRINE-RELATED CANCER
- Roles of microRNAs during prostatic tumorigenesis and tumor progression
- (2013) Y-X Fang et al. ONCOGENE
- Androgen receptor splice variants are resistant to inhibitors of Hsp90 and FKBP52, which alter androgen receptor activity and expression
- (2013) Ayesha A. Shafi et al. STEROIDS
- PIAS1 Is Increased in Human Prostate Cancer and Enhances Proliferation through Inhibition of p21
- (2012) Julia Hoefer et al. AMERICAN JOURNAL OF PATHOLOGY
- Androgen receptor primes prostate cancer cells to apoptosis through down-regulation of basal p21 expression
- (2012) Yuting Lin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
- (2012) N. J. Clegg et al. CANCER RESEARCH
- Epigenetic Repression of miR-31 Disrupts Androgen Receptor Homeostasis and Contributes to Prostate Cancer Progression
- (2012) P.-C. Lin et al. CANCER RESEARCH
- Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer
- (2012) R. Hu et al. CANCER RESEARCH
- Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
- (2012) Y. Li et al. CANCER RESEARCH
- Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: Effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys
- (2012) Masuo Yamaoka et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Effect of a novel 17,20-lyase inhibitor, orteronel (TAK-700), on androgen synthesis in male rats
- (2012) Takahito Hara et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
- (2012) Karim Fizazi et al. LANCET ONCOLOGY
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma
- (2012) K Boll et al. ONCOGENE
- Characterisation of a Tip60 Specific Inhibitor, NU9056, in Prostate Cancer
- (2012) Kelly Coffey et al. PLoS One
- The activity of the androgen receptor variant AR-V7 is regulated by FOXO1 in a PTEN-PI3K-AKT-dependent way
- (2012) Sanjay N. Mediwala et al. PROSTATE
- FOXA1 Promotes Tumor Progression in Prostate Cancer and Represents a Novel Hallmark of Castration-Resistant Prostate Cancer
- (2011) Josefine Gerhardt et al. AMERICAN JOURNAL OF PATHOLOGY
- Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer
- (2011) Tomohiro Kaku et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen responsiveness of prostate cancer cells
- (2011) Yu-Wei Chou et al. CANCER LETTERS
- Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
- (2011) P. Ostling et al. CANCER RESEARCH
- Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy
- (2011) Y. Sun et al. CANCER RESEARCH
- Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
- (2011) C. Cai et al. CANCER RESEARCH
- Targeting Continued Androgen Receptor Signaling in Prostate Cancer
- (2011) C. Massard et al. CLINICAL CANCER RESEARCH
- Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants
- (2011) Elahe A. Mostaghel et al. CLINICAL CANCER RESEARCH
- Androgen receptor levels are upregulated by Akt in prostate cancer
- (2011) S. Ha et al. ENDOCRINE-RELATED CANCER
- Alternatively spliced androgen receptor variants
- (2011) Scott M Dehm et al. ENDOCRINE-RELATED CANCER
- MicroRNA let-7c Suppresses Androgen Receptor Expression and Activity via Regulation of Myc Expression in Prostate Cancer Cells
- (2011) Nagalakshmi Nadiminty et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of the Acetyltransferases p300 and CBP Reveals a Targetable Function for p300 in the Survival and Invasion Pathways of Prostate Cancer Cell Lines
- (2011) F. R. Santer et al. MOLECULAR CANCER THERAPEUTICS
- Small Molecule Inhibition of the Steroid Receptor Coactivators, SRC-3 and SRC-1
- (2011) Ying Wang et al. MOLECULAR ENDOCRINOLOGY
- Androgen-Induced Cell Migration: Role of Androgen Receptor/Filamin A Association
- (2011) Gabriella Castoria et al. PLoS One
- Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival
- (2011) Emma Hörnberg et al. PLoS One
- The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study
- (2011) Jayaprakash Karkera et al. PROSTATE
- Multicenter Phase II Trial of the Heat Shock Protein 90 Inhibitor, Retaspimycin Hydrochloride (IPI-504), in Patients With Castration-resistant Prostate Cancer
- (2011) William K. Oh et al. UROLOGY
- MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer
- (2010) Oskar W Rokhlin et al. CANCER BIOLOGY & THERAPY
- Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor
- (2010) Raymond J. Andersen et al. CANCER CELL
- Tubulin-Targeting Chemotherapy Impairs Androgen Receptor Activity in Prostate Cancer
- (2010) M.-L. Zhu et al. CANCER RESEARCH
- Phase I Dose-Escalation Study of the Novel Antiandrogen BMS-641988 in Patients with Castration-Resistant Prostate Cancer
- (2010) D. Rathkopf et al. CLINICAL CANCER RESEARCH
- miR 488* inhibits androgen receptor expression in prostate carcinoma cells
- (2010) Kavleen Sikand et al. INTERNATIONAL JOURNAL OF CANCER
- Phosphorylation and Activation of Androgen Receptor by Aurora-A
- (2010) Shao-Kun Shu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate Cancer
- (2010) Daniel C. Danila et al. JOURNAL OF CLINICAL ONCOLOGY
- Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study
- (2010) Howard I Scher et al. LANCET
- FKBP51 Promotes Assembly of the Hsp90 Chaperone Complex and Regulates Androgen Receptor Signaling in Prostate Cancer Cells
- (2010) L. Ni et al. MOLECULAR AND CELLULAR BIOLOGY
- MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1α/HIF-1β
- (2010) Paul Cao et al. Molecular Cancer
- Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases
- (2010) Y Liu et al. ONCOGENE
- Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
- (2010) P. A. Watson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Androgen regulation of micro-RNAs in prostate cancer
- (2010) Kati K. Waltering et al. PROSTATE
- Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)
- (2009) L. R. Molife et al. ANNALS OF ONCOLOGY
- miR-21: An Androgen Receptor-Regulated MicroRNA that Promotes Hormone-Dependent and Hormone-Independent Prostate Cancer Growth
- (2009) J. Ribas et al. CANCER RESEARCH
- Discovery of BMS-641988, a Novel and Potent Inhibitor of Androgen Receptor Signaling for the Treatment of Prostate Cancer
- (2009) R. M. Attar et al. CANCER RESEARCH
- A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
- (2009) Z. Guo et al. CANCER RESEARCH
- Histone Deacetylases Are Required for Androgen Receptor Function in Hormone-Sensitive and Castrate-Resistant Prostate Cancer
- (2009) D. S. Welsbie et al. CANCER RESEARCH
- The Role of microRNA-221 and microRNA-222 in Androgen-Independent Prostate Cancer Cell Lines
- (2009) T. Sun et al. CANCER RESEARCH
- Interleukin-6 Regulates Androgen Synthesis in Prostate Cancer Cells
- (2009) J. Y. Chun et al. CLINICAL CANCER RESEARCH
- Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells
- (2009) Frédéric R Santer et al. ENDOCRINE-RELATED CANCER
- Interleukin-6 increases prostate cancer cells resistance to bicalutamide via TIF2
- (2009) S. Feng et al. MOLECULAR CANCER THERAPEUTICS
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
- (2009) C. Tran et al. SCIENCE
- Targeted Overexpression of Vav3 Oncogene in Prostatic Epithelium Induces Nonbacterial Prostatitis and Prostate Cancer
- (2008) Y. Liu et al. CANCER RESEARCH
- The RNA Helicase p68 Is a Novel Androgen Receptor Coactivator Involved in Splicing and Is Overexpressed in Prostate Cancer
- (2008) E. L. Clark et al. CANCER RESEARCH
- The Nuclear Factor- B Pathway Controls the Progression of Prostate Cancer to Androgen-Independent Growth
- (2008) R. J. Jin et al. CANCER RESEARCH
- Androgen Levels Increase by Intratumoral De novo Steroidogenesis during Progression of Castration-Resistant Prostate Cancer
- (2008) J. A. Locke et al. CANCER RESEARCH
- Androgen Receptor and Invasion in Prostate Cancer
- (2008) T. Hara et al. CANCER RESEARCH
- Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation
- (2008) A. Seaton et al. CARCINOGENESIS
- A Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Hormone-Refractory Metastatic Prostate Cancer
- (2008) E. I. Heath et al. CLINICAL CANCER RESEARCH
- Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor
- (2008) Kamilla Malinowska et al. ENDOCRINE-RELATED CANCER
- Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven
- (2008) Gerhardt Attard et al. JOURNAL OF CLINICAL ONCOLOGY
- Androgen receptor inactivation contributes to antitumor efficacy of 17 -hydroxylase/17,20-lyase inhibitor 3 -hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer
- (2008) T. Vasaitis et al. MOLECULAR CANCER THERAPEUTICS
- Leupaxin, a Novel Coactivator of the Androgen Receptor, Is Expressed in Prostate Cancer and Plays a Role in Adhesion and Invasion of Prostate Carcinoma Cells
- (2008) Silke Kaulfuss et al. MOLECULAR ENDOCRINOLOGY
- Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival
- (2008) Y Wang et al. ONCOGENE
- FOXO3a mediates the androgen-dependent regulation of FLIP and contributes to TRAIL-induced apoptosis of LNCaP cells
- (2008) A N Cornforth et al. ONCOGENE
- Src kinase potentiates androgen receptor transactivation function and invasion of androgen-independent prostate cancer C4-2 cells
- (2008) M Asim et al. ONCOGENE
- Oligomeric proanthocyanidin complexes (OPC) exert anti-proliferative and pro-apoptotic effects on prostate cancer cells
- (2008) Hannes Neuwirt et al. PROSTATE
- Stimulation of Prostate Cancer Cellular Proliferation and Invasion by the Androgen Receptor Co-Activator ARA70β
- (2007) Yi Peng et al. AMERICAN JOURNAL OF PATHOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started